Mostrando 2 resultados de: 2
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
ArticleAbstract: Environmental or lifestyle factors are likely to explain part of the heterogeneity in breast and ovaPalabras claves:BRCA1, BRCA2, Breast Cancer, Ovarian Cancer, parityAutores:Baiget M., Balmaña J., Benitez J., Blanco A., Blanco I., Caldés T., Calvo M.T., Chirivella I., De la Hoya M., Díaz-Rubio E., Durán M., Esteban-Cardeñosa E., Guillén-Ponce C., Lasa A., Lázaro C., Martínez De Dueñas E., Milne R.L., Miramar M.D., Osorio A., Ramón Y Cajal T., Raquel Salazar-Lugo, San Román C., Sánchez-Ollé G., Tejada M.I., Teulé A., Urioste M., Vega A., Velasco E.Fuentes:scopusThe average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain
ArticleAbstract: Purpose: It is not clear that the published estimates of the breast and ovarian cancer penetrances oPalabras claves:Autores:Antoniou A.C., Benitez J., Beristain E., Blanco A., Blanco I., Caldés T., Calvo M.T., Carmen Alonso M., Chirivella I., De la Hoya M., Díez O., Durán M., Esteban-Cardeñosa E., Graña B., Guillén-Ponce C., Lázaro C., Llort G., Martínez E., Milne R.L., Miramar M.D., Osorio A., Ramón Y Cajal T., Raquel Salazar-Lugo, Román C.S., Sánchez-de-Abajo A., Tejada M.I., Urioste M., Vega A., Velasco E.Fuentes:scopus